EFTR - eFFECTOR Therapeutics GAAP EPS of -$0.22 beats by $0.02 revenue of $0.67M beats by $0.01M March, 08 2023 06:07 PM eFFECTOR Therapeutics Inc. 2023-03-08 18:07:01 ET eFFECTOR Therapeutics press release ( NASDAQ: EFTR ): Q4 GAAP EPS of -$0.22 beats by $0.02 . Revenue of $0.67M (+116.1% Y/Y) beats by $0.01M . For further details see: eFFECTOR Therapeutics GAAP EPS of -$0.22 beats by $0.02, revenue of $0.67M beats by $0.01M